Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/27/2013EP2666481A2 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
11/27/2013EP2666465A1 Novel dosage and formulation
11/27/2013EP2666464A1 Stable pharmaceutical composition comprising aripirazole
11/27/2013EP2666463A1 Stabilized liquid composition comprising pemetrexed
11/27/2013EP2666461A1 Terpene extract for the treatment of hair loss
11/27/2013EP2666364A1 Additives for animal food
11/27/2013EP2666358A1 Treating Psychological Conditions Using Muscarinic Receptor M1 Antagonists
11/27/2013EP2666356A1 Rasagiline for parkinson's disease modification
11/27/2013EP2666016A1 Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles
11/27/2013EP2666015A1 Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
11/27/2013EP2666014A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
11/27/2013EP2665830A2 Platelet analysis system
11/27/2013EP2665816A1 Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit
11/27/2013EP2665738A1 Compounds for use in the treatment of bacterial infection
11/27/2013EP2665736A1 Corona-like (guanidyl)-oligosaccharidic derivatives as cell-penetrating enhancers for intracellular delivery of colloidal therapeutic systems
11/27/2013EP2665732A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors
11/27/2013EP2665730A1 Compounds with super-aspirin effects
11/27/2013EP2665729A1 Piperazine derivatives as cav2.2 calcium channel blockers
11/27/2013EP2665728A2 Preparation method of intermediate of sitagliptin
11/27/2013EP2665727A1 Bicyclic carboxamide inhibitors of kinases
11/27/2013EP2665726A2 Compositions and methods for cardiovascular disease
11/27/2013EP2665725A1 Bicyclic inhibitors of alk
11/27/2013EP2665724A1 Bicyclic inhibitors of alk
11/27/2013EP2665720A1 2-methoxy-pyridin-4-yl derivatives
11/27/2013EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
11/27/2013EP2665713A1 1,4 oxazines as bace1 and/or bace2 inhibitors
11/27/2013EP2665712A1 Quinazolinone inhibitors of dynein
11/27/2013EP2665711A1 Picolinamide inhibitors of kinases
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013EP2665708A2 Modulators of tlr3/dsrna complex and uses thereof
11/27/2013EP2665707A1 Mineralocorticoid receptor antagonists
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665704A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
11/27/2013EP2665701A2 Diazeniumdiolate derivatives
11/27/2013EP2665492A1 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
11/27/2013EP2665491A1 Kit for the localized activation of high concentrations of a drug and the procedure thereof
11/27/2013EP2665484A1 Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
11/27/2013EP2665482A1 Wound healing device and method
11/27/2013EP2665481A2 Methods and compositions for treating metabolic syndrome
11/27/2013EP2665480A2 Pharmaceutical compositions and methods for making and using them
11/27/2013EP2665479A1 Methods and drug products for treating alzheimer's disease
11/27/2013EP2665478A1 Treatment of cognitive dysfunction in schizophrenia
11/27/2013EP2665477A1 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
11/27/2013EP2665476A2 Compounds and methods for enhancing hair growth
11/27/2013EP2665475A2 N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease
11/27/2013EP2665474A1 Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
11/27/2013EP2665473A2 Equine nutritional supplement
11/27/2013EP2665472A1 Compounds for treatment of heart failure
11/27/2013EP2665471A2 Controlled release oral pharmaceutical dosage forms comprising mgbg
11/27/2013EP2665468A2 Pharmaceutical compositions of immunosuppressants
11/27/2013EP2665467A2 Flavonol compositions
11/27/2013EP2665466A1 Solid molecular dispersion
11/27/2013EP2665465A1 Orally dispersible tablet
11/27/2013EP2665362A1 Olefin containing nuclear transport modulators and uses thereof
11/27/2013CN1918242B Compositions containing CI-isomers of carotenoids and preparation method
11/27/2013CN1899275B Use of composition of rheinic acid or rheinic acid compounds in preparing medicine for treating osteoarthritis
11/27/2013CN103415525A Bromodomain inhibitors and uses thereof
11/27/2013CN103415521A 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
11/27/2013CN103415519A 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
11/27/2013CN103415518A Imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment hyperproliferative disorders
11/27/2013CN103415516A Bicyclic inhibitors of ALK
11/27/2013CN103415515A Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
11/27/2013CN103415514A Method for producing phenoxypyridine derivative
11/27/2013CN103415513A Benzodioxane inhibitors of leukotriene production
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103415506A Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
11/27/2013CN103415297A A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
11/27/2013CN103415296A Fiber and probiotics for reducing intestinal symptoms related to chronic stress
11/27/2013CN103415295A Fiber and probiotics for reducing intestinal symptoms related to stress
11/27/2013CN103415293A Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
11/27/2013CN103415292A Androgen composition for treating an opthalmic condition
11/27/2013CN103415291A Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone by using a dosing algorithm to provide analgesia
11/27/2013CN103415290A Compounds useful for treating AIDS
11/27/2013CN103415289A Pro-neurogenic compounds
11/27/2013CN103415288A Internal parasiticide
11/27/2013CN103415287A Treatment of type II diabetes and diabets-associated diseases with safe chemical mitochondrial uncouplers
11/27/2013CN103415286A Compounds and methods for treating pain
11/27/2013CN103415285A Pharmaceutical composition comprising opioid agonist and sequestered antagonist
11/27/2013CN103415284A Pharmaceutical formulation for producing rapidly disintegrating tablets
11/27/2013CN103415283A Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
11/27/2013CN103415218A 饮料 Beverages
11/27/2013CN103409272A Glutinous rice brewed yellow wine and preparation method thereof
11/27/2013CN103408677A Periodate-oxidized heparan sulfate for inhibiting cell proliferation
11/27/2013CN103408665A N-substituted tetrahydropyridine connected-5-substitured indole-monoclonal antibody CD33 conjugate and CD34 conjugate and preparation methods and application thereof
11/27/2013CN103408612A Phenanthrene and dihydrophenanthrene compounds and application thereof
11/27/2013CN103408606A N-(2-deoxy-lactose-2-group)-3-(substituted phenyl) acrylamide and medical application thereof
11/27/2013CN103408573A Boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408572A Chiral amino boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408571A Crystal form I of rifabutin, and preparation method and application thereof
11/27/2013CN103408554A Hypertensive activity reducing pyrrole coumarins compound and preparation method thereof
11/27/2013CN103408550A 2,5-diketopiperazine dipeptide derived from lysobacter enzymogenes as well as preparation method and application thereof
11/27/2013CN103408546A 2-phenylaminopurine PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408541A Indole-substituted thiazolo cyclohexane compound and antineoplastic applications thereof
11/27/2013CN103408540A 2-imidazole ring-substituted thiophene PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408537A 5-substituted dihydrobenzofuran-imidazolium salt compound and preparation method thereof
11/27/2013CN103408533A Novel substituted pyridin-2-ones and pyridazin-3-ones
11/27/2013CN103408530A Coumarin skeleton polycyclic compound with biological activity as well as preparation method and use thereof
11/27/2013CN103408528A Chroman compound, as well as preparation method and application thereof
11/27/2013CN103408504A Clozapine crystal compound, nanometer rapidly disintegrating tablet and preparation methods of clozapine crystal compound, a nanometer rapidly disintegrating tablet
11/27/2013CN103408501A Benzyl pyrimidine derivatives, and preparation method and medical application thereof
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 7860